Sun Pharma shares in focus as co announces plan to acquire Checkpoint Therapeutics for $355 million
Sun Pharmaceutical announced the acquisition of Nasdaq-listed Checkpoint Therapeutics, an immunotherapy and oncology company. The deal involves an upfront cash payment of $4.10 per share, totaling up to $355 million, with additional potential payouts based on…
Sun Pharmaceutical announced the acquisition of Nasdaq-listed Checkpoint Therapeutics, an immunotherapy and oncology company. The deal involves an upfront cash payment of $4.10 per share, totaling up to $355 million, with additional potential payouts based on…
Read More
About Author
